Hariri Robert J

Average Profitability
<0.0001%
Insider Buys Quantity
5
Insider Buys Sum
$3.14M
Insider Sells Quantity
8
Insider Sells Sum
$179,053.80

Insider Activity of Hariri Robert J

According to the SEC Form 4 filings, Hariri Robert J, being in a position of

  1. director at Cryoport, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 5500 shares for $43,060,
    over all time since 2022-08-11, has bought 0 shares, and sold 10800 shares for $179,054.

The largest purchase of all time was on 2023-09-29 and amounted to 9064539 shares of Celularity Inc. for $1.5M.

The largest sale of all time was on 2022-08-11 and amounted to 2000 shares of Cryoport, Inc. for $86,581.

Biography of Hariri Robert J

No biography is available at this moment.

2024-11-21SaleCryoport, Inc.
CYRX
director
2,500
0.005%
$6.48$16,200+17.94%
2024-08-19SaleCryoport, Inc.
CYRX
director
1,000
0.002%
$9.46$9,465-16.29%
2024-08-16SaleCryoport, Inc.
CYRX
director
1,000
0.0023%
$9.00$9,000-1.17%
2024-08-14SaleCryoport, Inc.
CYRX
director
1,000
0.0022%
$8.40$8,395-1.17%
2023-12-14SaleCryoport, Inc.
CYRX
director
800
0.0017%
$16.89$13,512-31.5%
2023-12-11SaleCryoport, Inc.
CYRX
director
1,000
0.0021%
$15.50$15,500-20.84%
2023-10-05PurchaseCelularity Inc.
CELU
Chief Executive Officer
9.36M
3.306%
$0.16$1.48M+42.18%
2023-09-29PurchaseCelularity Inc.
CELU
Chief Executive Officer
9.06M
3.3418%
$0.17$1.5M+35.14%
2023-09-06SaleCryoport, Inc.
CYRX
director
1,500
0.0031%
$13.60$20,400+3.52%
2022-11-30PurchaseCelularity Inc.
CELU
Chief Executive Officer
10,000
0.0383%
$1.72$17,175-66.08%
2022-11-29PurchaseCelularity Inc.
CELU
Chief Executive Officer
40,000
0.1524%
$1.71$68,400-65.27%
2022-11-28PurchaseCelularity Inc.
CELU
Chief Executive Officer
40,000
0.155%
$1.74$69,600-64.36%
2022-08-11SaleCryoport, Inc.
CYRX
2,000
0.0041%
$43.29$86,581-51.43%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.